These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26429399)

  • 21. Gene-Expression-Based Predictors for Breast Cancer.
    Gupta A; Mutebi M; Bardia A
    Ann Surg Oncol; 2015 Oct; 22(11):3418-32. PubMed ID: 26215189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Identification of predictive biomarkers to radiotherapy outcome through proteomics approaches].
    Lacombe J; Mange A; Azria D; Solassol J
    Cancer Radiother; 2013 Feb; 17(1):62-9; quiz 70, 72. PubMed ID: 23287796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteopontin C mRNA expression is associated with a poor clinical outcome in human breast cancer.
    Patani N; Jiang W; Mokbel K
    Int J Cancer; 2008 Jun; 122(11):2646. PubMed ID: 18302153
    [No Abstract]   [Full Text] [Related]  

  • 24. [Genetic bases of the radiosensitivity of breast cancer].
    Delaloge S; Marsiglia H
    Cancer Radiother; 2005 Mar; 9(2):77-86. PubMed ID: 15820435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PSMD9 expression predicts radiotherapy response in breast cancer.
    Langlands FE; Dodwell D; Hanby AM; Horgan K; Millican-Slater RA; Speirs V; Verghese ET; Smith L; Hughes TA
    Mol Cancer; 2014 Mar; 13():73. PubMed ID: 24673853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The evolution of accelerated, partial breast irradiation as a potential treatment option for women with newly diagnosed breast cancer considering breast conservation.
    Dirbas FM; Jeffrey SS; Goffinet DR
    Cancer Biother Radiopharm; 2004 Dec; 19(6):673-705. PubMed ID: 15665616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insights into the theranostic value of precision medicine on advanced radiotherapy to breast cancer.
    Jiang M; Yang J; Li K; Liu J; Jing X; Tang M
    Int J Med Sci; 2021; 18(3):626-638. PubMed ID: 33437197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered fractionation: rationale and justification for whole and partial breast hypofractionated radiotherapy.
    Théberge V; Whelan T; Shaitelman SF; Vicini FA
    Semin Radiat Oncol; 2011 Jan; 21(1):55-65. PubMed ID: 21134655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ductal carcinoma in situ of the breast: the importance of morphologic and molecular interactions.
    Mardekian SK; Bombonati A; Palazzo JP
    Hum Pathol; 2016 Mar; 49():114-23. PubMed ID: 26826418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The future of breast cancer radiotherapy: From one size fits all to taylor-made treatment].
    Hennequin C; Azria D
    Cancer Radiother; 2011 Oct; 15(6-7):455-9. PubMed ID: 21820932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between androgen receptor expression, Ki-67 and the 21-gene recurrence score in non-metastatic, lymph node-negative, estrogen receptor-positive and HER2-negative breast cancer.
    Vera-Badillo FE; Chang MC; Kuruzar G; Ocana A; Templeton AJ; Seruga B; Goldstein R; Bedard PL; Tannock IF; Amir E
    J Clin Pathol; 2015 Oct; 68(10):839-43. PubMed ID: 26076967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose Ionizing Radiation Regulates Gene Expression Changes in the MCF7 Breast Cancer Cell Line.
    Bravatà V; Minafra L; Russo G; Forte GI; Cammarata FP; Ripamonti M; Casarino C; Augello G; Costantini F; Barbieri G; Messa C; Gilardi MC
    Anticancer Res; 2015 May; 35(5):2577-91. PubMed ID: 25964533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraoperative radiotherapy for breast cancer.
    Vaidya JS; Tobias JS; Baum M; Keshtgar M; Joseph D; Wenz F; Houghton J; Saunders C; Corica T; D'Souza D; Sainsbury R; Massarut S; Taylor I; Hilaris B
    Lancet Oncol; 2004 Mar; 5(3):165-73. PubMed ID: 15003199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accelerated partial breast irradiation in early breast cancer: focus on intraoperative treatment with electrons (ELIOT).
    Zurrida S; Leonardi MC; Del Castillo A; Lazzari R; Arnone P; Caldarella P
    Womens Health (Lond); 2012 Jan; 8(1):89-98. PubMed ID: 22171778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is current evidence about intraoperative partial breast irradiation sufficient for broad implementation in clinical practice?
    Kaidar-Person O; Yarnold J; Offersen BV; Poortmans P
    Eur J Surg Oncol; 2014 Jul; 40(7):791-3. PubMed ID: 24721228
    [No Abstract]   [Full Text] [Related]  

  • 36. Pulsed dose rate brachytherapy as the sole adjuvant radiotherapy after breast-conserving surgery of T1-T2 breast cancer: first long time results from a clinical study.
    Johansson B; Karlsson L; Liljegren G; Hardell L; Persliden J
    Radiother Oncol; 2009 Jan; 90(1):30-5. PubMed ID: 18410975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective.
    Gebski V; Lagleva M; Keech A; Simes J; Langlands AO
    J Natl Cancer Inst; 2006 Jan; 98(1):26-38. PubMed ID: 16391369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current status of accelerated partial breast irradiation.
    Mitsumori M; Hiraoka M
    Breast Cancer; 2008; 15(1):101-7. PubMed ID: 18224403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contemporary issues in the use of radiation therapy for early invasive breast cancer.
    Wazer DE
    Surg Oncol Clin N Am; 2000 Jul; 9(3):585-601, x. PubMed ID: 10853144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relative biological effectiveness of photon energies used in brachytherapy and intraoperative radiotherapy techniques for two breast cancer cell lines.
    Marthinsen AB; Gisetstad R; Danielsen S; Frengen J; Strickert T; Lundgren S
    Acta Oncol; 2010 Nov; 49(8):1261-8. PubMed ID: 20735284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.